The push for lower prescription drug prices, spearheaded by recent policy changes, offers a tempting vision of relief at the pharmacy. However, a closer look reveals a complex web of potential consequences that could fundamentally alter the landscape of pharmaceutical innovation in the United States.
TRUMP'S HEALTHCARE LIE: Economists EXPOSE the SHOCKING Cost!
